Illumina, Inc. (ILMN)
131.54
-0.72
(-0.54%)
USD |
NASDAQ |
Apr 16, 13:49
Illumina Research and Development Expense (Annual) : 951.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Labcorp Holdings, Inc. | -- |
| Guardant Health, Inc. | 364.19M |
| Natera, Inc. | 624.11M |
| GeneDx Holdings Corp. | 70.84M |
| Mettler-Toledo International, Inc. | 199.37M |